Clinical trial
Assessment of Translesional Markers and Metabolomics
NCT00321139 · Emory University, Other · Completed
Key facts
| NCT number | NCT00321139 |
|---|---|
| Title | Assessment of Translesional Markers and Metabolomics |
| Official title | An Assessment of Translesional Markers and Metabolomics |
| Lead sponsor | Emory University, Other |
| Collaborators | Boston Scientific Corporation Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Coronary Artery Disease |
| Enrollment | 50 |
| Start date | Apr 1, 2006 |
| Primary completion | Jan 1, 2007 |
| First posted | May 3, 2006 |
| Last update posted | Dec 15, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: